dcll9718s
mAbexperimentalADC
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 15, 2017 (NCT03298516)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- C-type lectin domain family 12 member ABINDING AGENT
binding agent - CLL1
Chemistry & pharmacology
- Payload
- unclear
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03298516 | Phase 1 | Nov 15, 2017 | Genentech, Roche |
Showing 1 of 1 trials
Page 1 / 1